Skip to main content

ESTUDIO CLINICO E IN VITRO DE LAS GLICOFORMAS DE APOC-III ASOCIADAS A LIPOPROTEINAS COMO BIOMARCADORES DE DIABETES Y SU ASOCIACION CON EL RIESGO CARDIOVASCULAR EN LA COHORTE PROSPECTIVA DI@BETES

PI21/01294

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2021
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE INVESTIGACION SANITARIA PERE VIRGILI
Execution centre FACULTAD DE MEDICINA Y CIENCIAS DE LA SALUD

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes

  • Guardiola, Montse
  • Rehues, Pere
  • Amigó, Núria|||0000-0002-0116-9145
  • Arrieta, Francisco|||0000-0001-7571-0451
  • Botana, Manuel|||0000-0002-3825-6111
  • Gimeno Orna, José Antonio|||0000-0002-9901-4992
  • Girona, Josefa
  • Martínez Montoro, José Ignacio
  • Ortega, Emilio|||0000-0002-2217-8905
  • Pérez, Antonio|||0000-0001-5528-1143
  • Sánchez Margalet, Víctor|||0000-0001-8638-8680
  • Pedro Botet Montoya, Juan|||0000-0001-7366-6821
  • Ribalta, Josep|||0000-0002-8879-4719
  • Aguilar, Manuel|||0000-0001-9657-5949
  • Becerra Fernández, Antonio
  • Botana, Manuel|||0000-0002-3825-6111
  • Campos Pastor, María del Mar
  • Durán García, Santiago
  • Fornos Pérez, José Antonio
  • Maldonado Castro, Gonzalo Fernando
  • Manrique Mutiozábal, Carmela Teresa
  • Mañas Martínez, Ana Belén
  • Mera Gallego, Inés
  • Montánez Fernández, Laura
  • Navarro Pérez, Jorge|||0000-0001-7414-7126
  • Obaya Rebollar, Juan Carlos|||0000-0002-2879-1743
  • Ortega, Emilio|||0000-0002-2217-8905
  • Ortiz Zúñiga, Ángel Michael|||0000-0002-2982-5896
  • Pardo Franco, José Luis
  • Pedro Botet Montoya, Juan|||0000-0001-7366-6821
  • Pérez Sánchez, José Carlos
  • Puig Jové, Carlos|||0000-0001-9466-2627
  • Ribalta, Josep|||0000-0002-8879-4719
  • Tébar Massó, Francisco Javier
  • Zubiría Gortázar, Juan Manuel
The burden of cardiovascular disease is particularly high among individuals with diabetes, even when LDL cholesterol is normal or within the therapeutic target. Despite this, cholesterol accumulates in their arteries, in part, due to persistent atherogenic dyslipidaemia characterized by elevated triglycerides, remnant cholesterol, smaller LDL particles and reduced HDL cholesterol. The causal link between dyslipidaemia and atherosclerosis in T2DM is complex, and our contention is that a deeper understanding of lipoprotein composition and functionality, the vehicle that delivers cholesterol to the artery, will provide insight for improving our understanding of the hidden cardiovascular risk of diabetes. This narrative review covers three levels of complexity in lipoprotein characterization: 1-the information provided by routine clinical biochemistry, 2-advanced nuclear magnetic resonance (NMR)-based lipoprotein profiling and 3-the identification of minor components or physical properties of lipoproteins that can help explain arterial accumulation in individuals with normal LDLc levels, which is typically the case in individuals with T2DM. This document highlights the importance of incorporating these three layers of lipoprotein-related information into population-based studies on ASCVD in T2DM. Such an attempt should inevitably run in parallel with biotechnological solutions that allow large-scale determination of these sets of methodologically diverse parameters.